State Board of Administration of Florida Retirement System’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$859K Sell
25,732
-68,096
-73% -$1.69M ﹤0.01% 1377
2026
Q1
$1.97M Sell
93,828
-3,008
-3% -$67.7K ﹤0.01% 1032
2025
Q4
$2.23M Buy
96,836
+4,070
+4% +$134K ﹤0.01% 1008
2025
Q3
$2.79M Sell
92,766
-1,143
-1% -$34.3K ﹤0.01% 935
2025
Q2
$3.41M Buy
93,909
+470
+0.5% +$16.9K 0.01% 889
2025
Q1
$3.38M Hold
93,439
0.01% 871
2024
Q4
$3.93M Buy
93,439
+3,870
+4% +$192K 0.01% 849
2024
Q3
$4.98M Hold
89,569
0.01% 802
2024
Q2
$3.68M Buy
89,569
+1,896
+2% +$81K 0.01% 857
2024
Q1
$3.52M Buy
87,673
+2,104
+2% +$99.2K 0.01% 843
2023
Q4
$4.09M Buy
85,569
+1,087
+1% +$42.1K 0.01% 855
2023
Q3
$3.01M Buy
84,482
+200
+0.2% +$7.92K 0.01% 896
2023
Q2
$3.89M Sell
84,282
-3,391
-4% -$157K 0.01% 858
2023
Q1
$3.52M Hold
87,673
0.01% 867
2022
Q4
$4.06M Sell
87,673
-3,040
-3% -$120K 0.01% 823
2022
Q3
$3.76M Hold
90,713
0.01% 848
2022
Q2
$5.41M Buy
90,713
+5,162
+6% +$318K 0.01% 767
2022
Q1
$6.21M Sell
85,551
-1,101
-1% -$76.6K 0.01% 790
2021
Q4
$7.29M Buy
86,652
+439
+0.5% +$35.7K 0.01% 764
2021
Q3
$7.78M Sell
86,213
-2,040
-2% -$184K 0.02% 744
2021
Q2
$8.41M Buy
88,253
+64,228
+267% +$6.69M 0.02% 739
2021
Q1
$2.73M Sell
24,025
-1,820
-7% -$248K 0.01% 1007
2020
Q4
$3.58M Sell
25,845
-3,060
-11% -$363K 0.01% 947
2020
Q3
$2.38M Buy
28,905
+580
+2% +$48.1K 0.01% 991
2020
Q2
$2.22M Sell
28,325
-560
-2% -$37.1K 0.01% 990
2020
Q1
$1.28M Hold
28,885
﹤0.01% 1084
2019
Q4
$1.23M Sell
28,885
-150
-0.5% -$6.19K ﹤0.01% 1275
2019
Q3
$1.24M Hold
29,035
﹤0.01% 1242
2019
Q2
$1.84M Buy
29,035
+2,600
+10% +$165K ﹤0.01% 1079
2019
Q1
$1.83M Hold
26,435
﹤0.01% 1075
2018
Q4
$1.15M Buy
26,435
+116
+0.4% +$6.34K ﹤0.01% 1273
2018
Q3
$2.01M Hold
26,319
0.01% 1102
2018
Q2
$2.02M Buy
26,319
+1,100
+4% +$71K 0.01% 1088
2018
Q1
$1.29M Buy
25,219
+137
+0.5% +$6.9K ﹤0.01% 1301
2017
Q4
$1.16M Buy
25,082
+760
+3% +$37.3K ﹤0.01% 1376
2017
Q3
$1.29M Hold
24,322
﹤0.01% 1315
2017
Q2
$1.51M Hold
24,322
﹤0.01% 1195
2017
Q1
$1.65M Hold
24,322
﹤0.01% 1165
2016
Q4
$1.71M Hold
24,322
0.01% 1137
2016
Q3
$1.73M Sell
24,322
-20
-0.1% -$1.28K 0.01% 1109
2016
Q2
$1.19M Buy
24,342
+1,335
+6% +$86.4K ﹤0.01% 1289
2016
Q1
$1.46M Buy
23,007
+1,000
+5% +$65.4K 0.01% 1201
2015
Q4
$2.47M Buy
22,007
+1,390
+7% +$139K 0.01% 963
2015
Q3
$1.99M Buy
20,617
+15,266
+285% +$1.75M 0.01% 1062
2015
Q2
$548K Buy
+5,351
New +$415K ﹤0.01% 1902

Other funds holding RARE

State Board of Administration of Florida Retirement System's RARE Position: Q2 2026 in Review

State Board of Administration of Florida Retirement System reduced its Ultragenyx Pharmaceutical (RARE) stake by 73% in Q2 2026, selling an estimated $1.69M and leaving 25,732 shares worth $859K. The position accounts for ﹤0.01% of the portfolio, ranked #1377.

State Board of Administration of Florida Retirement System first reported a position in RARE in Q2 2015 and has held it in 45 quarters since. The position peaked at $8.41M in Q2 2021. 126 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • State Board of Administration of Florida Retirement System held 25,732 shares of Ultragenyx Pharmaceutical worth $859K as of Q2 2026.
  • State Board of Administration of Florida Retirement System sold 68,096 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $1.69M.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q2 2026, its #1377 holding.
  • State Board of Administration of Florida Retirement System first reported a position in Ultragenyx Pharmaceutical in Q2 2015 and has held it in 45 quarters since.
  • State Board of Administration of Florida Retirement System's Ultragenyx Pharmaceutical position peaked at $8.41M in Q2 2021.
  • 126 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2026, filed 10 Aug 2026.